Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 28;32(6):312.
doi: 10.3390/curroncol32060312.

Methylation Status of the Telomerase Reverse Transcriptase Promoter in Parotid Tumours and Adjacent Parotid Gland Tissue: A Pilot Study on the Implications for Recurrence and Development of Malignancy

Affiliations

Methylation Status of the Telomerase Reverse Transcriptase Promoter in Parotid Tumours and Adjacent Parotid Gland Tissue: A Pilot Study on the Implications for Recurrence and Development of Malignancy

António Paiva-Correia et al. Curr Oncol. .

Abstract

Background/objectives: The methylation of the hypermethylated oncological region (THOR) of human telomerase reverse transcriptase (hTERT) may forecast tumour aggressiveness. This pilot study aimed to evaluate THOR methylation as a potential biomarker for recurrence/malignant transformation in salivary gland pleomorphic adenomas (PA).

Methods: THOR methylation was assessed by quantitative pyrosequencing in 96 parotid tissue samples (benign and malignant), including non-neoplastic parotid tissue, PA, recurrent PA (rPA), and carcinomas, along with their adjacent tissues. TERT promoter mutations (TPMs) were analysed by Sanger sequencing.

Results: THOR methylation significantly differed across the seven groups. Malignant tissues showed higher THOR methylation than non-neoplastic tissues, whereas benign tumours showed no significant difference from non-neoplastic tissue. THOR methylation in rPA was closer to carcinoma than to normal tissue, similar in rPA and tissues adjacent to rPA, and higher in tissues adjacent to carcinomas than in non-neoplastic tissues. A subset of PA-adjacent tissues showed epigenetic alterations, suggesting an increased risk of recurrence or malignant transformation (5-15%). No TPMs were detected.

Conclusions: THOR methylation may add information to differentiate normal from carcinogenic tissues and, as such, may be included in a biomarkers panel. Epigenetic alterations in PA-adjacent tissues with normal histology highlight the need for improved diagnostic markers.

Keywords: THOR; biomarkers; cancer; hTERT; methylation; pleomorphic adenoma; salivary gland neoplasms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
THOR methylation in parotid tissue (non-neoplastic glands), tissue from all adjacent parotid gland tissues, and tissue from parotid gland carcinoma. Dotes lines correspond to Q1, median, and Q3.
Figure 2
Figure 2
THOR methylation in parotid tissue (non-neoplastic tissue) and tissue from pleomorphic adenoma (PA). Dotes lines correspond to Q1, median, and Q3.
Figure 3
Figure 3
THOR methylation in parotid tissue (non-neoplastic tissue) and tissue from recurrent pleomorphic adenoma (PA). Dotes lines correspond to Q1, median, and Q3.

Similar articles

References

    1. Blackburn E.H., Gall J.G. A tandemly repeated sequence at the termini of the extrachromossomal ribosomal RNA in Tetrahymena. J. Mol. Biol. 1978;120:33–53. doi: 10.1016/0022-2836(78)90294-2. - DOI - PubMed
    1. O’Sullivan R.J., Karlseder J. Telomeres: Protecting chromosomes against genome instability. Nat. Rev. Mol. Cell Biol. 2010;11:171–181. doi: 10.1038/nrm2848. - DOI - PMC - PubMed
    1. Finkel T., Serrano M., Blasco M.A. The common biology of cancer and ageing. Nature. 2007;448:767–774. doi: 10.1038/nature05985. - DOI - PubMed
    1. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed
    1. Castelo-Branco P., Choufani S., Mack S., Gallagher D., Zhang C., Lipman T., Lipman T., Zhukova N., Walker E.J., Martin D., et al. Differentially methylated region of the TERT promoter and risk for stratification of childhood brain tumours: An integrative genomic and molecular study. Lancet Oncol. 2013;14:534–542. doi: 10.1016/S1470-2045(13)70110-4. - DOI - PubMed

LinkOut - more resources